BiotechTube
Home/NRG Therapeutics/Paul Thompson
PT

Paul Thompson

Chief Development Officer

NRG Therapeutics

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Parkinson's DiseaseNeurodegenerative Diseases

NRG Therapeutics Pipeline

DrugIndicationPhase
NRG5051ALS/MND and Parkinson's DiseasePhase 1